Author:
Ameri Mahmoud,Daddona Peter E.,Maa Yuh-Fun
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Organic Chemistry,Pharmaceutical Science,Pharmacology,Molecular Medicine,Biotechnology
Reference22 articles.
1. McClung MR, San Martin J, Miller PD, Civitelli R, Bandeira F, Omizo M, et al. Opposite bone remodeling effects of teriparatide and alendronate in increasing bone mass. Arch Intern Med. 2005;165:1762–8.
2. Keaveny TM, Hoffman PE, Kepperdahl DL, Donely DW, Krohn K, Glass EV, et al. Comparison of the effects of teriparatide and alendronate on parameters of total hip strength assessed by finite element analysis (Abstract). J Bone Miner Res. 2007;22(Suppl 1):S75.
3. Keaveny TM, Hoffmann PF, Singh M, Palermo L, Bilezikian JP, Greenspan SL, et al. Femoral bone strength and its relation to cortical and trabecular changes after treatment with PTH, alendronate, and their combination as assessed by finite element analysis of quantitative CT scans. J Bone Miner Res. 2008;12:1974–82.
4. Saag KG, Shane E, Boonen S, Marin F, Donely DW, Taylor KA, et al. Teriparatide or alendronate in glucocorticoid-induced osteoporosis. N Engl J Med. 2007;357:2028–39.
5. Fraenkel L, Gulanski B, Wittink D. Patient treatment preferences for osteoporosis. Arthritis Rheum. 2006;5:729–35.
Cited by
45 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献